Organ-preserving surgical treatment of a patient with synchronous bilateral morphologically different renal cell carcinoma, inferior vena cava tumor thrombus and pyeloureteral segment stone: clinical case-Reference-Cited by-同舟云学术

Organ-preserving surgical treatment of a patient with synchronous bilateral morphologically different renal cell carcinoma, inferior vena cava tumor thrombus and pyeloureteral segment stone: clinical case

Published:2024-02-27 Issue:4 Volume:19 Page:119-124
ISSN:1996-1812
Container-title:Cancer Urology
language:
Short-container-title:Onkourologiâ

Author:

Turupaev K. A.¹^ORCID,Klimov A. V.²^ORCID,Khalmurzaev O. A.²^ORCID,Arakelyan G. A.²^ORCID,Ladyko D. D.²^ORCID,Bezhanova S. D.²^ORCID,Vorob’eva V. O.²^ORCID,Smirnova A. V.²^ORCID,Matveev V. B.²^ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Russian University of Medicine, Ministry of Health of Russia

2. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Abstract

Kidney cancer is the 3rd most common disease in oncological urology. In 4–10 % cases, tumor thrombus of the inferior vena cava is diagnosed. In literature, single-digit number of cases of organ-preserving surgical treatment of patients with kidney cancer complicated by tumor thrombus is described. The article presents a rare clinical case of synchronous bilateral morphologically different kidney cancer with tumor thrombus in the left renal vein, perirenal segment of the inferior vena cava, pyeloureteral segment stone in the right ureter.

Publisher

Publishing House ABV Press

Reference20 articles.

1. Globocan (IARC) 2020. Available at: https://gco.iarc.fr/today/data/factsheets/cancers/29-Kidney-fact-sheet.pdf.

2. State of oncological care in Russia in 2021. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 239 p. (In Russ.).

3. Zhang C., Li X., Hao H. et al. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. BJU Int 2012; 110(11 Pt B):E481–5. DOI: 10.1111/j.1464-410X.2012.11173.x

4. Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59(4):543–52. DOI: 10.1016/j.eururo.2010.12.013

5. Scosyrev E., Messing E.M., Sylvester R. et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65(2):372–7. DOI: 10.1016/j.eururo.2013.06.044